| Research Article |
View full article
October 22, 2015
|Vol. 2, Issue 2|
Impact of Human T-Lymphotropic Virus (HTLV I/II) Diagnosis on the Frequency of Mood Disorders in a Non-Endemic Area
Sergio Monteiro de Almeida, Meri Bordignon Nogueira, Rafaela Miravalhes, Thiago Mestre, Francisco Jaime Barbosa, Marise Zonta, Gabriel Santos Schafer, Indaiara Felisbino, Suzana Carstensen, Ana Cristina Medeiros, Indianara Rotta, Mirian Pelegrino Beltrame, Sonia Mara Raboni and Luine Rosele Vidal
Corresponding author: Sergio Monteiro de Almeida, MD, PhD, Hospital de Clinicas - UFPR, Secao de Virologia, Setor Analises Clinicas, Rua Padre Camargo, 280 Curitiba - PR - Brasil
Chronic diseases cause different impact to different people. We performed this study to evaluate the impact of human T-lymphotropic virus (HTLV I/II) diagnosis on the frequency of mood disorders. Of six HTLV I/II infected patients, including one asymptomatic, four reported depression at the moment of HTLV diagnosis. The findings reveal that it is crucial to inform patients of the HTLV diagnosis only after conducting confirmatory tests, as indicated by majority of diagnosis protocols. Usually countries with limited resources and a high prevalence of HTLV I/II infections do not perform confirmatory tests, including Brazil.
Citation: de Almeida SM, Nogueira MB, Miravalhes R, Mestre T, Barbosa FJ, et al. (2015) Impact of Human T-Lymphotropic Virus (HTLV I/II) Diagnosis on the Frequency of Mood Disorders in a Non-Endemic Area. Int J Virol AIDS 2:012.